Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AdvaMed Begets "AdvaMed Dx" For IVD-Focused Lobbying Effort

This article was originally published in The Gray Sheet

Executive Summary

AdvaMed is forming an "association within an association" to focus exclusively on in vitro diagnostics, the group announced Dec. 17

You may also be interested in...



AdvaMedDx’s New Chairman Is BD Exec Vince Forlenza

Becton Dickinson President Vince Forlenza is the new chairman of AdvaMedDx, the division of the Advanced Medical Technology Association focused on in vitro diagnostics, the group announced Oct. 20 at the AdvaMed 2010 conference in Washington, D.C.

AdvaMedDx’s New Chairman Is BD Exec Vince Forlenza

Becton Dickinson President Vince Forlenza is the new chairman of AdvaMedDx, the division of the Advanced Medical Technology Association focused on in vitro diagnostics, the group announced Oct. 20 at the AdvaMed 2010 conference in Washington, D.C.

AdvaMed Dx

Diagnostics firms bioMerieux, Gen-Probe and Quidel recently joined AdvaMed's newly formed in-vitro-diagnostics-focused AdvaMed Dx division (1"The Gray Sheet" Dec. 21, 2009). Each of the companies had been in AdavMed at one time, but had let their memberships lapse

Related Content

Topics

UsernamePublicRestriction

Register

MT028289

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel